Since DNMT3A mutation had an opposite influence on the phenomenon of increased proportion of Teff in AML relative to HDs, we individually compared DNMT3AWT and DNMT3AMu patients with HDs and clarified their distinct profiles. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.